Cell therapy involves the use of live whole cells or components of cells to replace or regenerate damaged tissues and cells in the body. It involves transplantation of human cells, tissues or organs into a patient to treat disease, manage a medical condition or restore or establish normal function. Common types of cell therapies include stem cell therapy, immunotherapy, and gene therapy. Stem cell therapy has emerged as an important therapeutic option for chronic and degenerative diseases, injuries and genetic disorders.

The global cell therapy market is estimated to be valued at US$ 844.7 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics

Increasing incidences of chronic diseases along with the approval and commercialization of innovative cell therapy products are the major drivers of the global cell therapy market growth. According to the Centers for Disease Control and Prevention (CDC), around 133 million Americans, representing more than 40% of the U.S. adult population suffer from at least one chronic disease. Additionally, WHO estimates that chronic diseases account for over 60% of all deaths globally. Cell therapy offers promising therapeutic options for chronic and degenerative diseases which is propelling the market growth. Further, increasing commercialization of CAR T-cell therapy for cancer and ongoing research for developing new cell therapies to treat cardiac diseases, diabetes, etc. are contributing to the market growth.

SWOT Analysis

Strength: The cell therapy market has witnessed huge investments in R&D from key players over the years. Cell therapy has shown promising results in treating various life-threatening diseases. Rising adoption of regenerative medicines is expected to drive the demand.

Weakness: High costs associated with cell therapy development and manufacturing limits its adoption. Stringent regulatory processes for product approvals can delay market launch. Limited medical infrastructure in developing regions hampers market growth.

Opportunity: Increasing prevalence of chronic diseases worldwide presents lucrative opportunities. Growing geriatric population susceptible to such diseases will boost demand. Expanding applications in oncology and neurological disorders offer scope for market expansion.

Threats: Safety issues related to cell therapies can adversely impact the market. Lack of skilled labor and technical experts poses challenges. Limited understanding of cell biology among patients acts as a restraint. Threat from alternative treatment options may impede revenue generation.

Key Takeaways

The Global Cell Therapy Market Size is expected to witness high growth. The global cell therapy market is estimated to be valued at US$ 844.7 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030.

The North American region currently dominates the global market and is expected to maintain its leading position during the forecast period. This is attributed to growing funding from private and public sources for cell-based research, increasing adoption of regenerative medicines, and supportive regulations in the region. On the other hand, Asia Pacific is poised to witness the fastest growth owing to rising healthcare expenditure, expanding patient pool, and increasing focus of prominent players on tapping opportunities in emerging Asian countries.

Key players operating in the cell therapy market are Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Mylan N.V., Par Pharmaceutical, Inc., Apotex Inc., Sandoz AG, Dr. Reddy's Laboratories Ltd., Accord Healthcare Ltd. Growing investment activities by these players to enhance their cell therapy portfolios will positively impact revenue growth of the global market in the coming years.

Explore more information on this topic, Please visit-
https://www.rapidwebwire.com/cell-therapy-market-size-and-share-analysis-growth-trends-and-forecasts/

Explore more trending article related this topic:
https://masstamilan.in/rise-of-off-price-retail-choosing-value-over-high-prices/